Navigation Links
Forte Research Systems Opens Their OnCore Software Developer Toolkit for Use With Any eIRB System

MADISON, Wis., June 29, 2011 /PRNewswire/ --

  • OnCore® Software Developer Toolkit (SDK) for eIRB integration now freely available.
  • Toolkit works with any eIRB system, including commercial and homegrown systems.
  • SDK model allows data to flow in either direction between Clinical Trials Management System (CTMS) and eIRB system.
  • Benefits include reduced manual data entry and more timely access to both clinical and regulatory data.

After proving the success of their electronic Institutional Review Board (eIRB) management system integration interface, Forte Research Systems, Inc. is making their Software Developers' Toolkit (SDK) freely available to all interested parties. The integrations were accomplished between Forte Research's market-leading product, the OnCore Clinical Research Management system, and various eIRB systems.


"As the market leader, we feel this was the right thing to do for our customers, not to mention the clinical research community as a whole," said Srini Kalluri, Founder, President, CEO and Chief Customer Experience Officer at Forte Research Systems. "There's no reason for every one of our customers to have to reinvent the wheel when they want to share data between their eIRB system and OnCore."

The organizations that have implemented the OnCore SDK to exchange data with their eIRB systems cite similar motivations for pursuing this method for systems integration. Goals include reducing the amount of manual data entry, reducing errors by creating a single point of data entry, improving efficiency, supporting more streamlined processes, and increasing the availability of information to the people who need it. Additionally, the SDK model allows data to be inserted into the OnCore database as easily as it may be extracted.

Two NCI-designated Cancer Centers have completed their integration between OnCore and their eIRB systems using the SDK. At the Huntsman Cancer Institute (HCI) in Salt Lake City, Utah, the integration was with their implementation of Click Commerce's eResearch Portal. The other completed implementation is at the University of Virginia Cancer Center, which integrated OnCore with their homegrown eIRB system.

Reducing duplicative data entry and making processes more efficient were the primary goals for the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill, as well. Their ongoing implementation of the OnCore SDK is focused on cross-populating data between OnCore and a homegrown eIRB system. This information is related to Scientific Review Committee and IRB activities. In addition to review data, information related to protocol staff, protocol sponsors, and general protocol information is an ultimate goal of this data exchange.

"When we get that data to cross-populate between the two systems and we can activate studies more efficiently, that will be a great outcome," said Mary O'Dwyer, Clinical Protocol Office Associate Director at Lineberger.

Currently, there are several vendors in the marketplace who are successfully addressing the needs of IRBs with computerized systems. The OnCore SDK is general purpose and works with any commercial or homegrown system.

"The SDK model for integration has several advantages over a single-purpose interface," said Tony O'Hare, PhD, Co-founder, Vice President of Engineering, and Chief Collaboration Officer at Forte Research Systems. "Perhaps the most important benefit is that the result is available to every OnCore customer regardless of which eIRB system is in place at their institution."

Like all of Forte Research's major development initiatives, the new SDK was developed as part of a collaborative project in which members of the OnCore community worked closely with the company and provided operational expertise throughout the development process.

The "build-it-once" development model that Forte Research implemented for this SDK is the same model the company has taken from the beginning when first developing the OnCore system 11 years ago.

"What we did for CTMS, we are bringing to clinical research systems integration. Our goal is to minimize the cost of services for our customers and eliminate the need for everyone to have to pay over and over again for the same set of tools," Kalluri said.

About Forte Research Systems

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers. The OnCore platform is the result of over a decade of experience working closely with large research organizations, including institutes funded by the National Institute of Health's Clinical and Translational Science Award (CTSA) program and forty percent of the NCI designated cancer centers. The company's newest offering, the cloud-based Allegro™ product line is built for clinical research operations excellence with no software to install and no systems administration required.

For information about the OnCore clinical research informatics platform, contact Forte Research Systems at (608) 826-6002 or visit the company online at

SOURCE Forte Research Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
2. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
3. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
4. Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone
5. Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
6. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
7. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
8. Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone
9. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
10. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
11. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
Post Your Comments:
(Date:11/26/2015)... 26, 2015 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ... which demands kidney transplantation is expected to boost the market ... for organ transplantation. --> 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ...
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... India , November 26, 2015 ... --> adds ... Report" and "Investigation Report on China ... and 2021 forecasts data and information ... . ...
Breaking Medicine Technology:
(Date:11/29/2015)... (PRWEB) , ... November 29, 2015 , ... Khanna Vision ... Board of Ophthalmology on November 25th 2015. Peer Certification by the Board ... of his specialty. Certification in Ophthalmology is first obtained after the completion of three ...
(Date:11/29/2015)... IL (PRWEB) , ... November 29, 2015 , ... Effective ... In addition starting on Black Friday Target is offering a “Buy One ... This is a rare opportunity to purchase IguanaMed at a discounted price. ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Trying to ... has created the COUCH BUDDY. "I conceived of this design due to personal experience ... for couch users. It promotes relaxation and convenience, as well as increases support. It ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):